NYU Langone Health
New York, 10016, United States
Location status: Recruiting
NCT Number: NCT07224191
The objective of this study is to determine how visuomotor exploration relates to hippocampal activity along its long axis. The study will investigate the neurophysiological mechanisms in the hippocampus during (1) visual exploration in surgical patients using high-resolution iEEG, and (2) ambulatory exploration in patients implanted with RNS devices.
Interested in participating?
Request Info18 year–70 year
All sexes
Interventional
Not applicable
New York, 10016, United States
Location status: Recruiting
Aim 1 - Visual Exploration in Surgical Patients Investigators will study 20 surgical patients with high-resolution intracranial EEG (iEEG) to investigate hippocampal activity during visual exploration. Participants will view between 10-15 panoramic environments using Meta Quest AR/VR glasses while their eye movements and head turns are tracked. Eye-tracking, head-turn, and iEEG data will be synchronized with visual stimuli, and intracranial EEG and single-unit data will be analyzed for changes in neuronal firing and brain activity before and after saccades.
Aim 2 - Ambulatory Exploration in RNS Patients and Healthy Controls Investigators will study 12 epilepsy patients with implanted responsive neurostimulator (RNS) devices and 24 healthy controls (HCs) during real-world exploration. Participants will walk through and explore visually distinct rooms while wearing synchronized high-density EEG (hdEEG), eye-tracking glasses, and body position sensors. Data from hippocampal iEEG, hdEEG, eye tracking, and motion sensors will be synchronized offline to examine brain-behavior relationships and the influence of cognitive load on saccade-hippocampal interactions.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
All subjects:
Aim 1: Surgical epilepsy patients' inclusion criteria
Aim 2: RNS patients Inclusion criteria
Aim 2: Healthy Control Inclusion criteria • Able to walk and wear research equipment without assistance
Exclusion criteria
RNS patients, Aim 2:
All subjects:
Cognitive testing while admitted to the epilepsy monitoring unit (number of sessions will vary depending on patient availability and stamina).
Series of cognitive tasks completed during a study visit.
Time frame: Study Visit (Day 1)
Aims 1 and 2. High cognitive loads defined as visual exploration of a complex scene with goal-driven task.
Time frame: Study Visit (Day 1)
Aims 1 and 2. Medium cognitive loads defined as visual exploration of a simpler scene with fewer objects.
Time frame: Study Visit (Day 1)
Aims 1 and 2. Low cognitive loads defined as visual exploration of moving dots.
Time frame: Study Visit (Day 1)
Aims 1 and 2. Low cognitive loads defined as staring at a blank field of view or REM sleep.
Time frame: Study Visit (Day 1)
Aims 1 and 2. High cognitive loads defined as visual exploration of a complex scene with goal-driven task.
Time frame: Study Visit (Day 1)
Aims 1 and 2. Medium cognitive loads defined as visual exploration of a simpler scene with fewer objects.
Time frame: Study Visit (Day 1)
Aims 1 and 2. Low cognitive loads defined as staring at a blank field of view or REM sleep.
Time frame: Study Visit (Day 1)
Aims 1 and 2. Low cognitive loads defined as staring at a blank field of view or REM sleep.
Contact information is provided by the study sponsor or research team.
Anli Liu, MD, MA
CONTACT
Ayelet Rosenberg
CONTACT
NYU Langone Health
Other
Human Hippocampal Oscillations During Visuomotor Exploration
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02107989
Brain Diseases, Central Nervous System Diseases
Bethesda, Maryland, United States
View Trial DetailsNCT02531880
Brain Diseases, Central Nervous System Diseases
Bethesda, Maryland, United States
View Trial DetailsNCT01273129
Brain Diseases, Central Nervous System Diseases
Bethesda, Maryland, United States
View Trial DetailsNCT04715646
Brain Diseases, Central Nervous System Diseases
Hawthorne, New York, United States
View Trial Details